Clinical trial · Observational
Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma
Results of Phase III Study to Assess if Zoledronic Acid Have Antumor Activity in Multiple Myeloma
NCT01234129CI-TRIAL-00004084completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Assess the impact in outcome of the use of zoledronic acid in multiple myeloma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Multiple Myeloma | Multiple Myeloma | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| zoledronic acid | Drug | Zoledronic Acid | ALIAS |
Design
Arms and outcomes
Arms (3)
- label
- zoledronic acid or not zoledronic acid
- description
- patients with multiple myeloma will be treated with cytoreductive therapy following by zoledronic acid or not.
- interventionNames
- Drug: zoledronic acid
- label
- zoledronic acid or not zoledronic acid
- description
- patients with multiple myeloma will be treated with cytoreductive therapy following by stem cell transplant and did not received zoledronic acid
- interventionNames
- Drug: zoledronic acid
- label
- zoledronic acid
- description
- Patients with multiple treated with cytoreductive therapy following by stem cell transplant will be planned to received zoledronic acid
- interventionNames
- Drug: zoledronic acid
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: Diagnosis of multiple myeloma No previous treatment Symptomatic High risk (ISS) or stage III ( Durie-Salmon) No severe comorbidities - Exclusion Criteria: Pregnancy HIV + Refuse treatment \-
References
Publications (0)
Data not yet available
No reference posted for this study.